Does RUXOLITINIB Cause Transfusion? 64 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Transfusion have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
64
Reports of Transfusion with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
5
Deaths
29
Hospitalizations
How Dangerous Is Transfusion From RUXOLITINIB?
Of the 64 reports, 5 (7.8%) resulted in death, 29 (45.3%) required hospitalization.
Is Transfusion Listed in the Official Label?
Yes, Transfusion is listed as a known adverse reaction in the official FDA drug label for RUXOLITINIB.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
Which RUXOLITINIB Alternatives Have Lower Transfusion Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE